ANAPTYSBIO, INC (ANAB) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $234.60M | +157.0% |
| 2024 | $91.28M | +432.0% |
| 2023 | $17.16M | +66.8% |
| 2022 | $10.29M | -83.7% |
| 2021 | $63.17M | -15.8% |
| 2020 | $75.00M | +837.5% |
| 2019 | $8.00M | +60.0% |
| 2018 | $5.00M | -50.0% |
| 2017 | $10.00M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $234.60M | +157.0% |
| 2024 | $91.28M | +432.0% |
| 2023 | $17.16M | +66.8% |
| 2022 | $10.29M | -83.7% |
| 2021 | $63.17M | -15.8% |
| 2020 | $75.00M | +837.5% |
| 2019 | $8.00M | +60.0% |
| 2018 | $5.00M | -50.0% |
| 2017 | $10.00M | — |